1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
5. Asia Pacific Over-the-Counter Drugs MARKET BY product category
5.1. Introduction
5.2. Cough, Cold and Flu Products
5.3. Analgesics
5.4. Dermatology products
5.5. Gastrointestinal products
5.6. Vitamins, minerals and supplements (VMS)
5.7. Weight loss/Dietary products
5.8. Ophthalmic Products
5.9. Sleep Aids
5.10. Others
6. Asia Pacific Over-the-Counter Drugs MARKET BY administration
6.1. Introduction
6.2. Oral
6.3. Topical
6.4. Parenteral
7. Asia Pacific Over-the-Counter Drugs MARKET BY geography
7.1. Introduction
7.2. China
7.3. Japan
7.4. India
7.5. Australia
7.6. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.2. Novartis AG
9.3. Bayer AG
9.4. Sanofi
9.5. Pfizer, Inc.
9.6. GlaxoSmithKline plc.
9.7. Boehringer Ingelheim GmbH
9.8. Haleon Plc
9.9. Abbott Laboratories
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES